Author:
Kalra Sanjay,Atkin Stephen,Cervera Antonio,Das Ashok Kumar,Demir Ozgur,Demir Tevfik,Fariduddin Md.,Vo Khoa Tuan,Ku Bon Jeong,Kumar Ajay,Latif Zafar A.,Malek Rachid,Matawaran Bien J.,Mehta Roopa,Tran Nam Quang,Panelo Araceli,Ruder Sundeep,Saldana Joel Rodriquez,Shaikh Khalid A.,Shakya Amit,Shrestha Dina,Unnikrishnan A. G.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference18 articles.
1. Garber J. The importance of titrating starting insulin regimens in patients with type 2 diabetes. Diabetes Obes Metab. 2009;11(5):14–8.
2. Inzucchi S, Bergenstal R, Buse J, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Diabetes Care. 2012;35:1364–79.
3. Nathan M, Buse J, Davidson B, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care. 2009;32:193–203.
4. COMUNICADO: Ryzodeg® Significantly reduces the risk of low blood sugar in people with type 2 diabetes who fast during Ramadan.
http://www.europapress.es/comunicados/internacional-00907/noticia-comunicado-ryzodeg-significantly-reduces-the-risk-of-low-blood-sugar-in-people-with-type-diabetes-who-fast-during-ramadan-20171207094659.html
. Accessed 12 Feb 2018.
5. Ryzodeg® Summary of product characteristics 2015.
http://www.ema.europa.eu/docs/en_GB/document...Product.../WC500139011.pdf
. Accessed 16 May 2018
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献